Literature DB >> 7726391

Early expression of chromogranin A and tyrosine hydroxylase during prenatal development of the bovine adrenal gland.

I Totzauer1, W Amselgruber, F Sinowatz, M Gratzl.   

Abstract

The present study was undertaken to define the temporal pattern and distribution of cells positive for chromogranin A (CgA) and tyrosine hydroxylase (TH) in various developmental stages of fetal bovine adrenal gland. CgA is an acidic protein, co-stored and co-released with amines and a variety of peptide hormones and neurotransmitters in dense core vesicles of neural and endocrine cells and can be used as a marker for these cells and their malignant counterparts. TH is the rate-limiting enzyme in catecholamine biosynthesis and reflects noradrenergic differentiation. The expression of CgA and TH was examined by immunohistochemistry. CgA immunoreactivity appears first in 35-day-old bovine fetuses. By the end of the second month, CgA-labelled cells are scattered throughout the entire primordium of the adrenal gland, and at a fetal age of 85-91 days most of these cells concentrate in the developing adrenal medulla. From this stage onwards, immunoreactive cells of the marginal zone of the medulla exhibit significantly stronger CgA immunoreaction than the central area. TH immunoreactivity appeared in the adrenal primordium for the first time at the end of the second month of gestation. The distribution pattern of TH-positive cells was similar to that described for CgA, and no significant differences in topographical arrangement between TH- and CgA-positive cells can be detected. The results show that bovine adrenal chromaffin cells express CgA already during their earliest stages of development and prior to TH. The stronger immunoreaction of marginal adrenal medullary cells suggests an adrenalcortical effect of glucocorticoids on the expression of CgA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7726391     DOI: 10.1007/bf00186785

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  16 in total

1.  Early fetal acquisition of the chromaffin and neuronal immunophenotype by human adrenal medullary cells. An immunohistological study using monoclonal antibodies to chromogranin A, synaptophysin, tyrosine hydroxylase, and neuronal cytoskeletal proteins.

Authors:  W M Molenaar; V M Lee; J Q Trojanowski
Journal:  Exp Neurol       Date:  1990-04       Impact factor: 5.330

2.  The determination of the adrenal medullary cell fate during embryogenesis.

Authors:  K Seidl; K Unsicker
Journal:  Dev Biol       Date:  1989-12       Impact factor: 3.582

3.  Is chromogranin a prohormone?

Authors:  L E Eiden
Journal:  Nature       Date:  1987 Jan 22-28       Impact factor: 49.962

4.  Developmental potential of quail dorsal root ganglion cells analyzed in vitro and in vivo.

Authors:  H Rohrer; A L Acheson; J Thibault; H Thoenen
Journal:  J Neurosci       Date:  1986-09       Impact factor: 6.167

5.  Chromogranins, widespread in endocrine and nervous tissue, bind Ca2+.

Authors:  F U Reiffen; M Gratzl
Journal:  FEBS Lett       Date:  1986-01-20       Impact factor: 4.124

6.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

7.  Role of glucocorticoids in expression of the adrenergic phenotype in rat embryonic adrenal gland.

Authors:  M C Bohn; M Goldstein; I B Black
Journal:  Dev Biol       Date:  1981-02       Impact factor: 3.582

8.  Localisation of chromogranin A and B, met-enkephalin-arg6-gly7-leu8 and PGP9.5-like immunoreactivity in the developing and adult rat adrenal medulla and extra-adrenal chromaffin tissue.

Authors:  C Kent; R E Coupland
Journal:  J Anat       Date:  1989-10       Impact factor: 2.610

9.  Chromogranin A in the pancreatic islet: cellular and subcellular distribution.

Authors:  M Ehrhart; D Grube; M F Bader; D Aunis; M Gratzl
Journal:  J Histochem Cytochem       Date:  1986-12       Impact factor: 2.479

Review 10.  The chromogranins A and B: the first 25 years and future perspectives.

Authors:  H Winkler; R Fischer-Colbrie
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

View more
  1 in total

1.  Review of the history and current status of cell-transplant approaches for the management of neuropathic pain.

Authors:  Mary J Eaton; Yerko Berrocal; Stacey Q Wolfe; Eva Widerström-Noga
Journal:  Pain Res Treat       Date:  2012-06-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.